Reducing bottlenecks in clinical trial site initiation is crucial for accelerating the development of new treatments. Delays in starting trials can slow down the entire research process, prolonging the time it takes to bring effective therapies to patients. Streamlining site initiation improves efficiency, reduces costs, enhances patient recruitment, and ensures faster delivery of potentially life-saving medications. Learn more on how CenExel reduces bottlenecks here --> cenexel.com #CenExel #ClinicalTrials #CentersofExcellence
CenExel’s Post
More Relevant Posts
-
🌟 Championing Diversity & Equity for Healthier Communities 🌟 | Public Health Researcher | Mental Health Advocate
🌟 Let's talk about the power of listening to patients and the promising future of precision treatment through pharmacogenomics! 🌟 Have you ever felt like a medication just isn't working for you, despite its reputation for effectiveness? It's essential to recognize that each person is unique, and our genetic makeup plays a significant role in how we respond to medications. This is where pharmacogenomics steps in, offering a groundbreaking approach to personalize treatments based on individual genetic profiles. By embracing pharmacogenomics, healthcare providers can tailor medications to suit each patient's genetic characteristics, maximizing effectiveness and safety. This means fewer instances of adverse reactions and more successful treatment outcomes. It's a game-changer in healthcare, shifting the focus from a one-size-fits-all approach to one that prioritizes the individual needs of each patient. But it's not just about improving current treatments; it's also about paving the way for a future where precision medicine is the norm. Imagine a world where more patients can benefit from treatments precisely tailored to their genetic makeup, leading to better health outcomes and enhanced quality of life. So, let's listen to our patients when they share their experiences with medications. Let's acknowledge that genetic diversity means not everyone responds the same way to a particular treatment. And let's embrace the potential of pharmacogenomics to revolutionize healthcare, offering personalized treatments that truly make a difference in people's lives. Together, we can pave the way for a future where precision treatment is accessible to all. #PrecisionMedicine #Pharmacogenomics #PersonalizedHealthcare 🚀💊🧬
👇 A 2-minute lesson highlighting the enormous potential of #pharmacoegnomics in optimizing medications, improving patient care and enhancing #pharmacist practice.👇 #JoinThePGxMovement ------------- If you liked this content and want to know more about #pharmacogenomics, sign up for FREE educational updates at https://lnkd.in/gn3p3fZT Or head over to www.apma.website to enrol in an upcoming cohort.
To view or add a comment, sign in
-
Embracing patients as partners is key in unlocking greater engagement and better science. Some things to think about when wanting to improve patient engagement: ⏰ Engage earlier ✨ Understand the value of gaining patient insights 🌏 Representation and diversity matters ⁉ Make clinical research easier for patients to find and understand Read more in our article below #biopharma # patientcentricity
The biopharma industry must embrace a sea change in patient engagement practices to succeed in today’s world. In our latest article we talk about six priorities for the industry to adopt to help improve patient engagement - from involving patients earlier for better business impact, to the need for better representation from diverse patient groups. Read more here > https://ow.ly/gbUO50PYxER #Biopharma #PatientCentricity Chris Maxted Kate Moss (nee Watkins) Laveshni Reddy
To view or add a comment, sign in
-
-
In the evolving landscape of healthcare, patient-centricity is taking center stage. Patients are not just recipients but integral parts of the process, especially in autologous CAR T-cell therapies. 🧠 They bring invaluable expertise about their illnesses. 💡 They're well-informed about treatments. 🗣️ They want a voice in therapy design. Premier Research offers up 5 game-changing strategies to foster patient-centricity in CAR T-cell therapy studies. Check out the infographic now and join the movement towards empowering patients in healthcare 📊💪 #PatientCentricity #Healthcare
To view or add a comment, sign in
-
Specialty Pharmacy Expert & Consultant with a focus on clinical and operational program development, accreditation, compliance, and patient safety
This week we are diving deeper into Specialty Pharmacy patient assessment and interventions! 🔍 Optimizing Patient Care: Targeted Assessment in Specialty Pharmacy ✨ If the patient is having a problem with his or her condition and/or drug therapy, ask targeted questions to better understand the situation and to make an appropriate recommendation: 1️⃣ Symptom Duration: Understanding the timeline of symptoms to unravel their context and progression. 2️⃣ Medication History: Exploring recent changes in medication to identify potential triggers. 3️⃣ Symptom Severity: Gauging the intensity and frequency of symptoms to grasp their impact. 4️⃣ Influencing Factors: Investigating factors that alleviate or exacerbate symptoms for a holistic understanding. 5️⃣ Patient Initiatives: Inquiring about patient-led efforts to alleviate symptoms, fostering a collaborative approach. 6️⃣ Provider Awareness: Ensuring communication with the healthcare provider and understanding their recommendations. By understanding the patient's experience, we create tailored solutions for improved outcomes. 🌟 #SpecialtyPharmacy #PatientCare #AssessmentExcellence #PersonalizedMedicine
To view or add a comment, sign in
-
🤔 Are you finding it hard to integrate inclusive patient engagement into your drug development process? Are the insights that you do gather not reaching their full impact potential? Our latest blog provides our top tips on breaking down the walls standing between you and effective inclusive patient engagement. From planning early to sharing detailed outcomes, we outline the key steps to improving #PatientEngagement, and in turn, #PatientOutcomes. Read the blog now, and get started on the path to enhanced inclusive patient engagement today: https://lnkd.in/esk-TEZd
To view or add a comment, sign in
-
-
Partner Content - Patient recruitment is still considered by sponsors, CROs and research sites as the biggest challenge to the successful development and marketisation of new therapies and medications, as was highlighted in Clariness latest whitepaper. Although in recent years, an increasing number of third-party providers have started offering patient recruitment services, most of these lack the expertise that ensures the quick start of recruitment and on-schedule completion of the study. Despite the increasing focus on patient recruitment, study delays are in fact increasing. ☞ Download their whitepaper in the comments section to learn more how europe's leading patient recruitment platform, ClinLife, accelerates study enrollment. - https://lnkd.in/dz3Dv_Te #clinicaltrials #patientenrollment #patientrecruitment
To view or add a comment, sign in
-
-
Clinical research is a cornerstone of the healthcare industry, driving medical progress, fostering innovation in treatments, and elevating patient care. Its pivotal role in disease comprehension, drug evaluation, and healthcare enhancement is undeniable. #clinicalresearch #healthcare #clinicalresearchprofessional #clinicalresearchassociate #medicalinnovation
To view or add a comment, sign in
-
We have thousands of examples and the savings have ranged from $1,000's to over $1,000,000's. Remember your PBM is probably receiving 30% or more of the cost from PhRMA as a "Class of Trade" financial incentive to influence them to dispense these expensive medications without comprehensive utilization management. We provide that Independent Utilization Management to ensure your members receive the best therapies and not just the most profitable therapies. We provide our clients with Better Outcomes and Lower Cost without changing PBMs. Please contact me to discuss how we can help you remove this conflict of interest that the CAA specifically requires employers to address and remove. #CEO #CFO #CHRO #Fiduciary #CAA #DoTheRightThing
Download the case study to find out how this group plan realized substantial savings after switching one member’s synovitis specialty medication to a more cost-effective and therapeutically equivalent medication through individualized clinical guidance: https://hubs.li/Q02mrc8n0 Better Outcomes and Lower Cost. #casestudy #pharmacysavings #specialtymedication
Case Study: Specialty Savings Success
To view or add a comment, sign in
-
Go To Market Leader / Pharmaceutical Marketing Leader / Medical Device Operations Executive / Patient Advocate / Mentor
5 Hallmarks of an effective Patient Support Program. It’s not ‘one size fits all’ as each brand and patient population is unique- let’s work together to develop the best program for your patients and customers.
#Patientsupportprograms simplify treatment journeys by removing barriers. Learn from #IQVIA patient support experts, Jaime Thompson, Jennifer Millard, and Michael Zilligen, about the five hallmarks of a highly effective patient support program. Read their recent Fierce Pharma article now. https://bit.ly/46TmBnE
To view or add a comment, sign in
-
Diversity in clinical trials is critical. It ensures that findings are broadly applicable and that therapies are safe and effective for everyone. At PharmaSols, we prioritise diverse patient recruitment, a focus that’s integral to the integrity and success of a trial. Dive into the importance of this subject in our new blog post. https://lnkd.in/gTABR3jF #ClinicalTrials #DiversePopulation #ResearchDiversity #PharmaSols #clinicalresearch #drugdevelopment
To view or add a comment, sign in
-